Howard R J, Lyon J A, Uni S, Saul A J, Aley S B, Klotz F, Panton L J, Sherwood J A, Marsh K, Aikawa M
J Cell Biol. 1987 May;104(5):1269-80. doi: 10.1083/jcb.104.5.1269.
The profound changes in the morphology, antigenicity, and functional properties of the host erythrocyte membrane induced by intraerythrocytic parasites of the human malaria Plasmodium falciparum are poorly understood at the molecular level. We have used mouse mAbs to identify a very large malarial protein (Mr approximately 300,000) that is exported from the parasite and deposited on the cytoplasmic face of the erythrocyte membrane. This protein is denoted P. falciparum erythrocyte membrane protein 2 (Pf EMP 2). The mAbs did not react with the surface of intact infected erythrocytes, nor was Pf EMP 2 accessible to exogenous proteases or lactoperoxidase-catalyzed radioiodination of intact cells. The mAbs also had no effect on in vitro cytoadherence of infected cells to the C32 amelanotic melanoma cell line. These properties distinguish Pf EMP 2 from Pf EMP 1, the cell surface malarial protein of similar size that is associated with the cytoadherent property of P. falciparum-infected erythrocytes. The mAbs did not react with Pf EMP 1. In one strain of parasite there was a significant difference in relative mobility of the 125I-surface-labeled Pf EMP 1 and the biosynthetically labeled Pf EMP 2, further distinguishing these proteins. By cryo-thin-section immunoelectron microscopy we identified organelles involved in the transit of Pf EMP through the erythrocyte cytoplasm to the internal face of the erythrocyte membrane where the protein is associated with electron-dense material under knobs. These results show that the intraerythrocytic malaria parasite has evolved a novel system for transporting malarial proteins beyond its own plasma membrane, through a vacuolar membrane and the host erythrocyte cytoplasm to the erythrocyte membrane, where they become membrane bound and presumably alter the properties of this membrane to the parasite's advantage.
由人类疟原虫恶性疟原虫的红细胞内寄生虫引起的宿主红细胞膜在形态、抗原性和功能特性方面的深刻变化,在分子水平上仍知之甚少。我们已使用小鼠单克隆抗体来鉴定一种非常大的疟疾蛋白(分子量约为300,000),该蛋白从寄生虫中输出并沉积在红细胞膜的细胞质面上。这种蛋白被称为恶性疟原虫红细胞膜蛋白2(Pf EMP 2)。这些单克隆抗体不与完整感染红细胞的表面发生反应,完整细胞的外源性蛋白酶或乳过氧化物酶催化的放射性碘化也无法作用于Pf EMP 2。这些单克隆抗体对感染细胞与C32无黑色素黑色素瘤细胞系的体外细胞黏附也没有影响。这些特性将Pf EMP 2与Pf EMP 1区分开来,Pf EMP 1是一种大小相似的细胞表面疟疾蛋白,与恶性疟原虫感染红细胞的细胞黏附特性有关。这些单克隆抗体不与Pf EMP 1发生反应。在一种寄生虫菌株中,125I表面标记的Pf EMP 1和生物合成标记的Pf EMP 2的相对迁移率存在显著差异,进一步区分了这些蛋白质。通过冷冻超薄切片免疫电子显微镜,我们确定了参与Pf EMP通过红细胞细胞质转运到红细胞膜内表面的细胞器,在那里该蛋白与凸起下的电子致密物质相关联。这些结果表明,红细胞内疟原虫已经进化出一种新的系统,用于将疟疾蛋白运输到其自身质膜之外,通过液泡膜和宿主红细胞细胞质到达红细胞膜,在那里它们与膜结合,并可能改变该膜的特性以利于寄生虫。